No Data
No Data
Medikit: Half Year Report - Term 42 (2024/04/01 - 2025/03/31)
Nissin Foods Holdings and others announced a share buyback on November 11th.
The stocks announced to set up their own stock acquisition frame on November 11th (Monday) are as follows: <7242> KYB 4.6 million shares (18.4%) 20 billion yen (24/11/12-24/11/12) <7749> MediKit 0.25 million shares (1.7%) 0.7 billion 11.75 million yen (24/11/12-25/2/28) <6180> GMO Broadcasting 0.02 million shares (1.1%) 0.1 billion yen (24/11/12-25/3/31) <8331> Chiba Silver 12 million shares (1.7%) 10 billion yen (24/11/
Recruit HD, 2Q operating profit increased by 13.4% to 269.7 billion yen
Recruit HD <6098> announced that the second quarter performance for the quarter ending March 2025 showed sales revenue increased by 5.4% year-on-year to 1.7987 trillion yen, and operating profit increased by 13.4% to 269.8 billion yen. All HR technology business, matching & solution business, and temporary staffing business reported revenue growth. It exceeded the consensus of around 255 billion yen. Operating profit for the fiscal year ending March 2025 was revised upwards from 390 billion yen to 442.7 billion yen. Consensus.
Medikit: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (consolidated)
Medikit: Notice Concerning Dividends from Surplus Funds (Interim Dividend)
Insider increases its stake in Medikit(7749.JP) to 34.58%
On Nov 7, 中島 崇 and related parties submitted the Change Report to Ministry of Finance. The report shows that 中島 崇 and related parties increased their holdings in $Medikit(7749.JP)$, with their joint
No Data
No Data